Literature DB >> 23790165

Expression of Ki-67 and p53 in meningiomas.

S Pavelin1, K Becic, G Forempoher, I Mrklic, Z Pogorelic, M Titlic, S Andelinovic.   

Abstract

UNLABELLED: Meningiomas account for about 30% of all primary brain tumors. It is difficult to predict the behaviour of meningiomas, and identification of protein markers responsible for the regulation of cell proliferation can be very helpful. The aim of this study was to evaluate immunohistochemical expression of Ki-67 and p53 in 170 meningiomas.A total number of 170 meningioma samples were classified according to WHO, immunohistochemically stained for Ki-67 and p53 and analysed using light microscope. Of 170 meningiomas analysed, 142 were grade I, 17 grade II and 11 grade III. Female to male ratio was 1.42:1. Statistically significant correlation was found between tumor grade and Ki-67 (p<0.001). There was significant correlation between Ki-67 levels and tumor subtypes (p=0.009). The optimal cut-off value for Ki-67 was 3.195. Tumors with Ki-67 ≤3.195 were 2 cm smaller than tumors with Ki-67 >3.195. Statistically significant correlation was found regarding p53 expression and tumor size (p=0.034). No correlation was established between Ki-67 or p53 and location of the tumor.According to positive correlation between tumor grade and subtype with Ki-67 levels, as well as positive correlation between Ki-67 and p53 with tumor size, indicate that Ki-67 and p53 might have influence on meningioma development and progression. KEYWORDS: meningioma, Ki-67, p53, immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23790165     DOI: 10.4149/neo_2013_062

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  14 in total

1.  Resected WHO grade I meningioma and predictors of local control.

Authors:  Kamila Nowak-Choi; Joshua D Palmer; James Casey; Ameet Chitale; Ingrid Kalchman; Elizabeth Buss; Scott W Keith; Sarah E Hegarty; Mark Curtis; Charalambos Solomides; Wenyin Shi; Kevin Judy; David W Andrews; Christopher Farrell; Maria Werner-Wasik
Journal:  J Neurooncol       Date:  2021-01-09       Impact factor: 4.130

2.  Are Osteopontin and Ki67 Expressions Different in Various Histologic Grades of Meningioma? An Iranian Experience.

Authors:  Forough Hashemi; Pegah Babaheidarian; Soheila Dabiran
Journal:  Iran J Pathol       Date:  2015

3.  Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.

Authors:  Nives Pećina-Šlaus; Anja Kafka; Tomislav Vladušić; Davor Tomas; Monika Logara; Josip Skoko; Reno Hrašćan
Journal:  Int J Exp Pathol       Date:  2016-06-12       Impact factor: 1.925

4.  Evaluation of P57, P53 and Ki67 Expression in Meningiomas.

Authors:  İlknur Küçükosmanoğlu; Meryem İlkay Eren Karanis; Yaşar Ünlü; İlker Çöven
Journal:  J Korean Neurosurg Soc       Date:  2022-04-14

5.  Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence.

Authors:  G Trott; J F S Pereira-Lima; C G S Leães; N P Ferreira; L M Barbosa-Coutinho; M C Oliveira
Journal:  Braz J Med Biol Res       Date:  2015-03-03       Impact factor: 2.590

6.  In situ characterization of stem cells-like biomarkers in meningiomas.

Authors:  Hanin Alamir; Mona Alomari; Abdulla Ahmed A Salwati; Mohamad Saka; Mohammed Bangash; Saleh Baeesa; Fahad Alghamdi; Angel Carracedo; Hans-Juergen Schulten; Adeel Chaudhary; Adel Abuzenadah; Deema Hussein
Journal:  Cancer Cell Int       Date:  2018-05-25       Impact factor: 5.722

7.  Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance.

Authors:  Anja Bukovac; Anja Kafka; Reno Hrašćan; Tomislav Vladušić; Nives Pećina-Šlaus
Journal:  Mol Clin Oncol       Date:  2019-10-15

8.  Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification.

Authors:  Juan Yu; Fan-Fan Chen; Han-Wen Zhang; Hong Zhang; Si-Ping Luo; Guo-Dong Huang; Fan Lin; Yi Lei; Liangping Luo
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

9.  Proliferative Potential, and Inflammatory Tumor Microenvironment in Meningioma Correlate with Neurological Function at Presentation and Anatomical Location-From Convexity to Skull Base and Spine.

Authors:  Johannes Wach; Tim Lampmann; Ági Güresir; Hartmut Vatter; Ulrich Herrlinger; Albert Becker; Silvia Cases-Cunillera; Michael Hölzel; Marieta Toma; Erdem Güresir
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

10.  Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer.

Authors:  Najeeb M Halabi; Alejandra Martinez; Halema Al-Farsi; Eliane Mery; Laurence Puydenus; Pascal Pujol; Hanif G Khalak; Cameron McLurcan; Gwenael Ferron; Denis Querleu; Iman Al-Azwani; Eman Al-Dous; Yasmin A Mohamoud; Joel A Malek; Arash Rafii
Journal:  PLoS Genet       Date:  2016-01-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.